Clinical Implications of Tumor Necrosis Factor-Alpha, Interleukin-6 and Resistin in Coronary Artery Disease
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48852#.VKIVucCAM4
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48852#.VKIVucCAM4
Author(s)
Tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) are
involved in the progression of coronary artery disease (CAD). The cytokines’
levels are associated with the severity of CAD. We have recently reported on
the association of resistin, a relatively novel cytokine with the pathogenesis
of cardiovascular disease (CVD). Although the inflammatory cytokines’ impact on
atherosclerosis is widely accepted, yet some controversy exists regarding the
involvement of these factors in atherogenesis. The current review highlights
the potential association of TNF-alpha, IL-6 and resistin SNPs (single
nucleotide polymorphisms) with CAD. Molecular genetics data along with the
intracellular signaling cascade mechanisms may have important clinical implications
in the treatment of CAD.
KEYWORDS
Cite this paper
Javed, Q. (2014) Clinical Implications of Tumor
Necrosis Factor-Alpha, Interleukin-6 and Resistin in Coronary Artery
Disease. World Journal of Cardiovascular Diseases, 4, 416-421. doi: 10.4236/wjcd.2014.49052.
| [1] |
Tracy, R.P. (2003) Thrombin,
Inflammation and Cardiovascular Disease. Chest, 124, 49S-57S. http://dx.doi.org/10.1378/chest.124.3_suppl.49S |
| [2] |
Braunwald, E. (2008) Review
Article: Biomarkers in Heart Failure. New England Journal of Medicine,
358, 2148-2159. http://dx.doi.org/10.1056/NEJMra0800239 |
| [3] |
Egashira, K. (2003) Molecular
Mechanisms Mediating Inflammation in Vascular Disease: Special Reference
to Monocyte Chemoattractant Protein-1. Hypertension, 41, 834-841. http://dx.doi.org/10.1161/01.HYP.0000051642.65283.36 |
| [4] |
Hansson, G.K. (2005) Review
Article: Inflmmation, Atherosseclerosis and Coronary Artery Disease. New
England Journal of Medicine, 352, 1685-1695. http://dx.doi.org/10.1056/NEJMra043430 |
| [5] |
Padovani, J.C., Pazin-Filho, A.,
Simoes, M.V., Marin-Neto, J.A., Zago, M.A. and Franco, R.F. (2000) Gene
Polymorphisms in the TNF Locus and the Risk of Myocardial Infarction.
Thrombosis Research, 100, 263-269. http://dx.doi.org/10.1016/S0049-3848(00)00315-7 |
| [6] |
Pearson, T.A., George, A.,
Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., et al.
(2003) Markers of Inflammation and Cardiovascular Disease: Application
to Clinical and Public Health Practice; A Statement for Healthcare
Professionals from the Centers for Disease Control and Prevention and
the American Heart Association. Circulation, 107, 499-511. http://dx.doi.org/10.1161/01.CIR.0000052939.59093.45 |
| [7] |
Calabrese, F., Elisa, C.,
Cristina, C., et al. (2004) Over Expression of Tumor Necrosis Factor
(TNF-a) and TNF-a Receptor-1 in Human Viral Myocarditis:
Clinicopathologic Correlations. Mordern Pathology, 17, 1108-1118. http://dx.doi.org/10.1038/modpathol.3800158 |
| [8] |
Levine, B., Kalman, J., Mayer,
L., et al. (1990) Elevated Circulating Levels of Tumor Necrosis Factor
in Severe Chronic Heart Failure. New England Journal of Medicine, 323,
236-241. http://dx.doi.org/10.1056/NEJM199007263230405 |
| [9] | Elahi, M.M. and Matata, B.M. (2005) Genetic Diversity of Tumour Necrosis Factor: Implications on Cardiovascular Complications of Polymorphisms at Position –308 in the Promoter Region. The Cardiology, 1, 179-188. |
| [10] | Brinkman, B.M. (1996) Relevance of the Tumor Necrosis Factor Alpha (TNF Alpha) –308 Promoter Polymorphism in TNF Alpha Gene Regulation. Journal of Inflammation, 46, 32-41. |
| [11] |
Patel, R., Lim, D.S., Reddy, D.,
Nagueh, S.F., Lutucuta, S., Sole, M.J., et al. (2000) Variants of
Trophic Factors and Expression of Cardiac Hypertrophy in Patients with
Hypertrophic Cardiomyopathy. Journal of Molecular and Cellular
Cardiology, 32, 2369-2377. http://dx.doi.org/10.1038/sj.ejhg.5201816 |
| [12] |
Mellick, G.D. (2007) TNF Gene
Polymorphism and Quantitative Trait Related to Cardiovascular Diseases:
Getting to the Heart of the Matter. European Journal of Human Genetics,
15, 609-611. http://dx.doi.org/10.1038/sj.ejhg.5201816 |
| [13] |
Deswal, A., Petersen, N.J.,
Feldman, A.M., Young, J.B., White, B.G. and Mann, D.L. (2001) Cytokines
and Cytokine Receptors in Advanced Heart Failure: An Analysis of the
Cytokine Database from the Vesnarinone Trial (VEST). Circulation, 103,
2055-2059. http://dx.doi.org/10.1161/01.CIR.103.16.2055 |
| [14] |
Torre-Amione, G., Kapadia, S.,
Benedict, C., Oral, H., Young, J.B. and Manna, D.L. (1996)
Proinflammatory Cytokine Levels in Patients with Depressed Left
Ventricular Ejection Fraction: A Report from the Studies of Left
Ventricular Dysfunction (SOLVD). Journal of American College of
Cardiology, 27, 1201-1206. http://dx.doi.org/10.1016/0735-1097(95)00589-7 |
| [15] |
Kubota, T., McNamara, D.M.,
Wang, J.J., Trost, M., McTiernan, C.F., Mann, D.L., et al. (1998)
Effects of Tumor Necrosis Factor Gene Polymorphisms on Patients with
Congestive Heart Failure. Circulation, 97, 2499-2501. http://dx.doi.org/10.1161/01.CIR.97.25.2499 |
| [16] | Bidwell, J., Keen, L., Gallagher, G., Kimberly, R., Huizinga, T., McDermott, M.F., et al. (1999) Cytokine Gene Polymorphism in Human Disease: On-Line Databases. Immunology, 1, 3-19. |
| [17] |
Castell, J.V., Gómez-Lechón,
M.J., David, M., Andus, T., Geiger, T., Trullenque, R., et al. (1989)
Interleukin-6 Is the Major Regulator of Acute Phase Protein Synthesis in
Adult Human Hepatocytes. FEBS Letters, 242, 237-239. http://dx.doi.org/10.1016/0014-5793(89)80476-4 |
| [18] |
Harris, T.B., Ferrucci, L.,
Tracy, R.P., Corti, M.C., Wacholder, S., Ettinger, W.H., et al. (1999)
Associations of Elevated Interleukin-6 and C-Reactive Protein in Levels
with Mortality in the Elderly. American Journal of Medicine, 106,
506-512. http://dx.doi.org/10.1016/S0002-9343(99)00066-2 |
| [19] |
Biasucci, L.M., Liuzzo, G.,
Grillo, R.L., Caligiuri, G., Rebuzzi, A.G., Buffon, A., et al. (1999)
Elevated Levels of C-Reactive Protein at Discharge in Patients with
Unstable Angina Predict Recurrent Instability. Circulation, 99, 855-860.
http://dx.doi.org/10.1161/01.CIR.99.7.855 |
| [20] |
Biasucci, L.M., Liuzzo, G.,
Fantuzzi, G., Caligiuri, G., Rebuzzi, A.G., Ginnetti, F., et al. (1999)
Increasing Levels of Interleukin (1L)-1Ra and IL-6 during the First Two
Days of Hospitalization in Unstable Angina Are Associated with Increased
Risk of IN-Hospital Coronary Events. Circulation, 99, 2079-2084. http://dx.doi.org/10.1161/01.CIR.99.16.2079 |
| [21] |
Tappia, P.S., Man, W.J. and
Grimble, R.F. (1995) Influence of Unsaturated Fatty Acids on the
Production of Tumour Necrosis Factor and Interleukin-6 by Rat Peritoneal
Macrophages. Molecular and Cell Biochemistry, 143, 89-98. http://dx.doi.org/10.1007/BF01816941 |
| [22] |
Maes, M., Song, C., Lin, A., De
Jongh, R., Van Gastel, A., Kenis, G., et al. (1998) The Effects of
Psychological Stress on Humans: Increased Production of Pro-Inflammatory
Cytokines and Th1-Like Response in Stress-Induced Anxiety. Cytokine,
10, 313-318. http://dx.doi.org/10.1006/cyto.1997.0290 |
| [23] |
Fishman, D., Faulds, G.,
Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S., et al. (1998)
The Effect of Novel Polymorphisms in the Interleukin-6 (IL-6) Gene on
IL-6 Transcription and Plasma IL-6 Levels, and an Association with
Systemic-Onset Juvenile Chronic Arthritis. Journal of Clinical
Investigation, 102, 1369-1376. http://dx.doi.org/10.1172/JCI2629 |
| [24] |
Losito, A., Kalidas, K.,
Santoni, S. and Jeffery, S. (2003) Association of Interleukin-6 ﹣174G/C
Promoter Polymorphism with Hypertension and Left Ventricular Hypertrophy
in Dialysis Patients. Kidney International, 64, 616-622. http://dx.doi.org/10.1046/j.1523-1755.2003.00119.x |
| [25] |
Humphries, S.E., Luong, L.A.,
Ogg, M.S., Hawe, E. and Miller, G.J. (2001) The Interleukin-6 174 G/C
Polymorphism Is Associated with Risk of Coronary Heart Disease and
Systolic Blood Pressure in Healthy Men. European Heart Journal, 22,
2243-2252. http://dx.doi.org/10.1161/hq0901.094280 |
| [26] |
Brull, D.J., Montgomery, H.E.,
Sanders, J., Dhamrait, S., Luong, L., Rumley, A., et al. (2001)
Interleukin-6 Gene ﹣174G > C and ﹣572G > C Promoter Polymorphisms
Are Strong Predictors of Plasma Interleukin-6 Levels after Coronary
Artery Bypass Surgery. Arteriosclerosis, Thrombosis, and Vascular
Biology, 21, 1458-1463. http://dx.doi.org/10.1161/hq0901.094280 |
| [27] |
Hussain, M., Asghar, M. and
Javed, Q. (2010) Resistin Gene Promoter Region Polymorphism and the Risk
of Hypertrophic Cardiomyopathy in Patients. Translational Research,
155, 142-147. http://dx.doi.org/10.1016/j.trsl.2009.10.002 |
| [28] |
Hussain, M., Bibi, S. and Javed,
Q. (2011) Heritability of Genetic Variants of Resistin Gene in Patients
with Coronary Artery Disease: A Family-Based Study. Clinical
Biochemistry, 44, 618-622. http://dx.doi.org/10.1016/j.clinbiochem.2011.02.013 |
| [29] | Sheth, T., Nair, C., Nargundkar, M., Anand, S. and Yusuf, S. (1999) Cardiovascular and Cancer Mortality Canadians of European, South Asian, and Chinese Origin from 1979 to 1993: An Analysis of 1.2 Million Deaths. Canadian Medical Association Journal, 161, 132-138. |
| [30] |
McPherson, R., Pertsemlidis, A.,
Kavaslar, N., Stewart, A., Roberts, R., Cox, D.R., et al. (2007) A
Common Allele on Chromosome 9 Associated with Coronary Heart Disease.
Science, 316, 1488-1491. http://dx.doi.org/10.1126/science.1142447 |
| [31] |
Helgadottir, A., Thorleifsson,
G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., et
al. (2007) A Common Variant on Chromosome 9p21 Affects the Risk of
Myocardial Infarction. Science, 316, 1491-1493. http://dx.doi.org/10.1126/science.1142842 |
| [32] |
Preuss, M., Konig, I.R.,
Thompson, J.R., Erdmann, J., Absher, D., Assimes, T.L., et al. (2010)
Design of the Coronary Artery Disease Genome-Wide Replication and
Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association
Meta-Analysis Involving More than 22 000 Cases and 60 000 Controls.
Circulation: Cardiovascular Genetics, 3, 1369-1376. http://dx.doi.org/10.1161/CIRCGENETICS.109.899443 |
| [33] |
Zhuang, J., Peng, W., Li, H.,
Wang, W., Wei, Y., Li, W. and Xu, Y. (2012) Methylation of p15INK4b and
Expression of ANRIL on Chromosome 9p21 Are Associated with Coronary
Artery Disease. PLoS ONE, 7, e47193. http://dx.doi.org/10.1371/journal.pone.0047193 |
| [34] |
Javed, Q. and Murtaza, I. (2013)
Therapeutic Potential of Tumor Necrosis Factor-Alpha Antagonists in
Patients with Chronic Heart Failure. Heart, Lung and Circulation, 22,
323-327. http://dx.doi.org/10.1016/j.hlc.2012.12.002 eww141230lx |
评论
发表评论